Elena Bobescu
About
In The Last Decade
Elena Bobescu
18 papers receiving 223 citations
Peers
Comparison fields: 5 of 77
- Biomedical Engineering 116
- Computational Mechanics 87
- Mechanical Engineering 48
- Cardiology and Cardiovascular Medicine 29
- Fluid Flow and Transfer Processes 18
Countries citing papers authored by Elena Bobescu
This map shows the geographic impact of Elena Bobescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Bobescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Bobescu more than expected).
Fields of papers citing papers by Elena Bobescu
This network shows the impact of papers produced by Elena Bobescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Bobescu. The network helps show where Elena Bobescu may publish in the future.
Co-authorship network of co-authors of Elena Bobescu
This figure shows the co-authorship network connecting the top 25 collaborators of Elena Bobescu. A scholar is included among the top collaborators of Elena Bobescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Bobescu. Elena Bobescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 0 | |
| 5 | 34 | |
| 6 | 2 | |
| 7 | 18 | |
| 8 | 41 | |
| 9 | 10 | |
| 10 | 13 | |
| 11 | 0 | |
| 12 | 21 | |
| 13 | 13 | |
| 14 | 7 | |
| 15 | 13 | |
| 16 | 1 | |
| 17 | 13 | |
| 18 | ROLE OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS IN HYPERTENSION AND CARDIOVASCULAR PROTECTION MANAGEMENT | 5 |
| 19 | 1 | |
| 20 | Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.